Juliana Rodrigues Beal (Juliana Beal)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Top Venues

International journal of molecular sciences

Current issues in molecular biology

Einstein (Sao Paulo, Brazil)

This page only lists publications with an associated author ORCID identifier.

Publications

Nicoly Marques de Castro, Fernando Moura, Aline Lury Hada, Diogo Garcia, Elivane da Silva Victor, Gustavo Schvartsman, Leonardo Carvalho, Milena Lourenço Coleta Fernandes, Rodrigo de Souza Martins, Elaine Ferreira da Silva, Sarah Silva Mello Batista Dos Santos, Letícia Taniwaki, Patrícia Taranto, Janaina Pontes, Juliana Rodrigues Beal, Ana Carolina Pereira Dutra, João Bosco de Oliveira Filho, Sérgio Eduardo Alonso Araujo, Pedro Luiz Serrano UsÓn Junior
Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study. Einstein (Sao Paulo, Brazil) 22 (2024)
Janaina Pontes Batista Cassoli, Ítalo Fernandes, Leonardo Carvalho, Milena Fernandes, Ana Fernanda Centrone, Letícia Taniwaki, Rita de Cássia Lima, Uelson Donizeti Rocioli Junior, Igor Wanderley Reis Dias, Patrícia Taranto, Juliana Rodrigues Beal, Fernanda Teresa de Lima, Fernando Moura, Miguel Cendoroglo, Sergio Eduardo Alonso Araújo, Pedro Luiz Serrano UsÓn Junior
Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing. Current issues in molecular biology 46 (8) (2024)
Janaina Pontes Batista Cassoli, Ítalo Fernandes, Leonardo Carvalho, Milena Fernandes, Ana Fernanda Centrone, Letícia Taniwaki, Rita de Cássia Lima, Uelson Donizeti Rocioli Junior, Igor Wanderley Reis Dias, Patrícia Taranto, Juliana Rodrigues Beal, Fernanda Teresa de Lima, Fernando Moura, Miguel Cendoroglo, Sergio Eduardo Alonso Araújo, Pedro Luiz Serrano UsÓn Junior
Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing. Current issues in molecular biology 46 (8) (2024)
Nicoly Marques de Castro, Fernando Moura, Aline Lury Hada, Diogo Garcia, Elivane da Silva Victor, Gustavo Schvartsman, Leonardo Carvalho, Milena Lourenço Coleta Fernandes, Rodrigo de Souza Martins, Elaine Ferreira da Silva, Sarah Silva Mello Batista Dos Santos, Letícia Taniwaki, Patrícia Taranto, Janaina Pontes, Juliana Rodrigues Beal, Ana Carolina Pereira Dutra, João Bosco de Oliveira Filho, Sérgio Eduardo Alonso Araujo, Pedro Luiz Serrano UsÓn Junior
Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study. Einstein (Sao Paulo, Brazil) 22 (2024)
Janaina Pontes Batista Cassoli, Ítalo Fernandes, Leonardo Carvalho, Milena Fernandes, Ana Fernanda Centrone, Letícia Taniwaki, Rita de Cássia Lima, Uelson Donizeti Rocioli Junior, Igor Wanderley Reis Dias, Patrícia Taranto, Juliana Rodrigues Beal, Fernanda Teresa de Lima, Fernando Moura, Miguel Cendoroglo, Sergio Eduardo Alonso Araújo, Pedro Luiz Serrano UsÓn Junior
Frequency of Deleterious Germline Variants in HER2-Low Breast Cancer Patients Using a Hereditary Multipanel Gene Testing. Current issues in molecular biology 46 (8) (2024)
Douglas Dias E Silva, Guilherme Bes Borba, Juliana Rodrigues Beal, Gehan Botrus, Akemi Osawa, Sérgio Eduardo Alonso Araújo, Fernando Moura, Rafael Aliosha Kaliks Guendelmann, Pedro Luiz Serrano Uson Junior
Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report. International journal of molecular sciences 24 (4) (2023)
Douglas Dias E Silva, Guilherme Bes Borba, Juliana Rodrigues Beal, Gehan Botrus, Akemi Osawa, Sérgio Eduardo Alonso Araújo, Fernando Moura, Rafael Aliosha Kaliks Guendelmann, Pedro Luiz Serrano Uson Junior
Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report. International journal of molecular sciences 24 (4) (2023)
Douglas Dias E Silva, Guilherme Bes Borba, Juliana Rodrigues Beal, Gehan Botrus, Akemi Osawa, Sérgio Eduardo Alonso Araújo, Fernando Moura, Rafael Aliosha Kaliks Guendelmann, Pedro Luiz Serrano Uson Junior
Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report. International journal of molecular sciences 24 (4) (2023)
Douglas Dias E Silva, Guilherme Bes Borba, Juliana Rodrigues Beal, Gehan Botrus, Akemi Osawa, Sérgio Eduardo Alonso Araújo, Fernando Moura, Rafael Aliosha Kaliks Guendelmann, Pedro Luiz Serrano Uson Junior
Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report. International journal of molecular sciences 24 (4) (2023)
Douglas Dias E Silva, Guilherme Bes Borba, Juliana Rodrigues Beal, Gehan Botrus, Akemi Osawa, Sérgio Eduardo Alonso Araújo, Fernando Moura, Rafael Aliosha Kaliks Guendelmann, Pedro Luiz Serrano Uson Junior
Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report. International journal of molecular sciences 24 (4) (2023)